90 subscribers
Gå frakoblet med Player FM -appen!
Was the ARRIVE Trial an IOL Mandate? (New ACOG CPU)
Manage episode 449150432 series 2280622
The ARRIVE was published in the New England Journal of Medicine on August 8, 2018 1. This study was a large unmasked multicenter trial conducted from March 2014 to August randomized 6,106 nulliparous women to either IOL or expectant management at full term. The trial was conducted at 41 facilities across the United States. This validated that eIOL at 39 weeks, in that patient population, had the ability to reduce cesarean sections and rates of hypertensive diseases of pregnancy. Since that time, elective IOLs have INCREASED at 39 weeks as some messaging was distorted implying that IOL was the BEST way to go over expectant management. Has other data since 2018 found the same thing? Or were the results of the ARRIVE trial an aberration? The ACOG has JUST RELEASED a new CPU which provides additional insights to this. Listen in for details!
949 episoder
Manage episode 449150432 series 2280622
The ARRIVE was published in the New England Journal of Medicine on August 8, 2018 1. This study was a large unmasked multicenter trial conducted from March 2014 to August randomized 6,106 nulliparous women to either IOL or expectant management at full term. The trial was conducted at 41 facilities across the United States. This validated that eIOL at 39 weeks, in that patient population, had the ability to reduce cesarean sections and rates of hypertensive diseases of pregnancy. Since that time, elective IOLs have INCREASED at 39 weeks as some messaging was distorted implying that IOL was the BEST way to go over expectant management. Has other data since 2018 found the same thing? Or were the results of the ARRIVE trial an aberration? The ACOG has JUST RELEASED a new CPU which provides additional insights to this. Listen in for details!
949 episoder
所有剧集
×1 Time for Stillbirth Prevention Bundle: NOW. 30:41
1 *FDA Warning*: RSV Vacc and GBS (Breaking it Down) 34:00
1 Response to 2 New Pubs: “Ya Don’t Say?!” (Sarcasm Added) 21:19
1 Mode of Delivery for Periviable PTB: Does it Matter? 41:39
1 MATISSE Trial: Maternal RSV Vaccine Outcomes 26:17
1 FDA Lit Review on Tampon Safety Released 21:21
1 2025 SFP Statement on BC and Body Weight 32:15
1 Fetal RHD Positive, Yet RH Blood Type Negative at Birth? YEP. 36:07
1 BRAND NEW USPSTF Recs (12/10/24) on HPV Screening 32:34
Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.